Element

Cd

Cdcar

Pb

Pbcar

Cr

Crcar

Ni

Nicar

Mn

Cu

Type of distribution

LogN

LogN

LogN

N

LogN

LogN

95% UCL

1.649

1.649

1.294

1.294

1.072

1.072

2.988

2.988

2.187

1.045

RfD_ing

1.00E−01

3.50E−03

3.00E−03

1.10E−02

1.40E−01

4.00E−02

RfD_inh

2.0E−05

1.00E−01

7.66E−05

5.00E−02

RfD_dermal

2.50E−05

3.50E−02

7.50E−05

4.40E−04

1.40E−01

4.00E−02

SF_inh

5.00E−01

5.00E−01

4.20E+01

8.40E−01

Children

CDI_ing (mg∙kg⁻¹∙d⁻¹)

9.29E+07

7.30E+00

6.04E+00

1.68E−06

1.23E−06

5.89E−07

CDI_inh (mg∙kg⁻¹∙d⁻¹)

2.60E−11

2.04E−11

1.69E−11

4.71E−11

3.44E−11

1.65E−11

CDI_dermal (mg∙kg⁻¹∙d⁻¹)

1.45E−02

1.13E−02

9.40E−03

2.62E−02

1.92E−02

9.16E−03

HQ_ing

9.29E+08

2.09E+03

2.01E+03

1.53E−04

8.79E−06

1.47E−05

HQ_inh

1.30E−05

1.69E−10

6.15E+15

6.88E−10

HQ_dermal

2.32E+04

3.23E−01

9.62E+03

1.49E+03

1.37E−01

HI = ∑HQ_i

9.29E+08

2.09E+03

1.16E+04

1.49E+03

6.15E+15

1.47E−05

Cancer Risk

1.30E−11

1.02E−11

7.10E−11

9.90E−10

Adult

CDI_ing (mg∙kg⁻¹∙d⁻¹)

1.16E−06

9.12E−07

7.55E−07

2.11E−06

1.54E−06

7.36E−07

CDI_inh (mg∙kg⁻¹∙d⁻¹)

1.71E−10

1.34E−10

1.06E−10

4.21E−10

3.08E−10

1.47E−10

CDI_dermal (mg∙kg⁻¹∙d⁻¹)

2.68E+00

2.11E+00

1.67E+00

4.86E+00

3.56E+00

1.70E+00

HQ_ing

1.16E−03

2.61E−04

1.01E−02

4.80E−03

1.10E−05

1.84E−05

HQ_inh

8.34E−08

1.06E−11

5.50E+01

6.16E−02

HQ_dermal

4.28E+06

6.03E+01

1.72E+06

2.75E+05

6.35E+01

4.25E+01

HI = ∑HQ_i

4.28E+06

6.03E+01

1.72E+06

2.75E+05

6.36E+01

4.25E+01

Cancer Risk

8.55E−11

6.70E−11

4.45E−09

8.61E−09